Involvement of the Endocannabinoid System in the pathophysiology and therapeutics of movement disorders
Introduction: Control of movement is a complex process within the brain. Although some approaches have been already made in the employment of cannabinoid-related compounds for the treatment of pathologies such as Parkinson's Disease (PD), there is a huge gap in the understanding of the role tha...
Main Authors: | A.R. Tejeda-Martínez, J.M. Viveros-Paredes, M.E. Flores-Soto |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Neurology Perspectives |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667049622000503 |
Similar Items
-
Biomarkers of Oxidative Stress in Huntington's Disease and Other Neurological Disorders: a Comparative Study
by: Marisol Peña Sánchez, et al.
Published: (2023-12-01) -
Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions
by: Tapan Behl, et al.
Published: (2020-08-01) -
Clinical and epidemiological variables in patients diagnosed with Parkinson's disease
by: Lázaro Raidel Moreira Díaz, et al.
Published: (2019-10-01) -
Clinical and epidemiological variables in patients diagnosed with Parkinson's disease
by: Lázaro Raidel Moreira Díaz, et al.
Published: (2019-10-01) -
Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
by: Alexandru Vasincu, et al.
Published: (2022-03-01)